NewRegen, Inc. (NREG)
- Previous Close
0.0090 - Open
0.0088 - Bid --
- Ask --
- Day's Range
0.0088 - 0.0088 - 52 Week Range
0.0023 - 0.0300 - Volume
100 - Avg. Volume
243,139 - Market Cap (intraday)
1.097M - Beta (5Y Monthly) 3.63
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NewRegen Inc. specializes in regenerative medicine, stem cell, and anti-aging research. It provides regenerative care that gives hope to patients, who suffer from diseases or injuries. The company was formerly known as Springs Rejuvenation Inc. NewRegen Inc. was incorporated in 2016 and is based in Atlanta, Georgia.
springsrejuvenation.com1
Full Time Employees
January 31
Fiscal Year Ends
Sector
Industry
Recent News: NREG
Performance Overview: NREG
Trailing total returns as of 6/3/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NREG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NREG
Valuation Measures
Market Cap
1.10M
Enterprise Value
1.10M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
168.23k
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: NREG
NREG does not have Company Insights